Scientists have demonstrated a creative new way to kill cancer cells effectively, with few side effects. Gluing two ...

The US Food and Drug Administration (FDA) has issued a draft guidance for testing the potency of cellular and gene therapy (CGT) products. The guidance clarifies the potency information needed to ...

Cell-based assays (CBAs) are key tools for evaluating the potency of new biologic drugs. Catalent’s transcription-based bioassay simplifies and empowers the testing of new biologics. CONTINUE TO SITE ...